These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1444758)

  • 1. Influence of [6S]-N5-formyltetrahydrofolic acid on the bioavailability of 5-fluorouracil combined with interferon-alpha-2b.
    Czejka MJ; Schüller J; Fogl U
    Arch Pharm (Weinheim); 1992 Jun; 325(6):373-4. PubMed ID: 1444758
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil.
    Schüller J; Czejka MJ; Schernthaner G; Fogl U; Jäger W; Micksche M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):93-7. PubMed ID: 1557661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of carmofur and interferon-alpha-2B in advanced gastrointestinal cancer--a phase II pilot study.
    Gröhn P; Helle L; Numminen S; Heinonen E
    Acta Oncol; 1994; 33(6):711-3. PubMed ID: 7946457
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced cytotoxicity of 5-fluorouracil combined with [6RS]leucovorin and recombinant human interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Adkins DA; Houghton PJ
    Adv Exp Med Biol; 1993; 339():133-42; discussion 165-7. PubMed ID: 8178712
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative treatment for advanced gastrointestinal cancer: is response a suitable end-point?
    Jäger E; Bernard H; Knuth A
    Cancer Treat Rev; 1996 Jan; 22 Suppl A():113-5. PubMed ID: 8625335
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer.
    Frasci G; Leone F; Monaco M; Cremone L; Sapio U; Faiella F; Espinosa A; Persico G
    Dis Colon Rectum; 1994 Jul; 37(7):643-50. PubMed ID: 8026229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic aspects of the combination of interferon-alpha-2b and folic acid with fluorouracil].
    Czejka MJ; Jäger W; Schüller J; Fogl U; Schernthaner G
    Arzneimittelforschung; 1991 Aug; 41(8):860-3. PubMed ID: 1781811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.
    Houghton JA; Cheshire PJ; Morton CL; Stewart CF
    Clin Cancer Res; 1995 Jan; 1(1):33-40. PubMed ID: 9815884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations.
    Grem JL; Chu E; Boarman D; Balis FM; Murphy RF; McAtee N; Allegra CJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):36-44. PubMed ID: 1557656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer.
    Cascinu S; Alessandroni P; Rossi D; Del Ferro E; Fedeli A; Casadei V; Catalano G
    Cancer Chemother Pharmacol; 1996; 38(4):385-6. PubMed ID: 8674163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
    Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
    Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Murphy RF; Hamilton JM; Balis F; Steinberg S; Arbuck SG; Setser A; Jordan E; Chen A
    J Clin Oncol; 1994 Mar; 12(3):560-8. PubMed ID: 8120554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 5-fluorouracil and recombinant alpha-2a-interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: a multicenter randomized study.
    Palmeri S; Gebbia V
    J Surg Oncol Suppl; 1991; 2():134-6. PubMed ID: 1892521
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
    Seymour MT; Patel N; Johnston A; Joel SP; Slevin ML
    Br J Cancer; 1994 Oct; 70(4):724-8. PubMed ID: 7917928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.
    Cascinu S; Fedeli A; Fedeli SL; Catalano G
    Ann Oncol; 1992 Jun; 3(6):489-91. PubMed ID: 1498068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to increase 5-fluorouracil activity with interferon-alpha 2a in the treatment of advanced colorectal cancer.
    Martoni A; Bidin L; Zamagni C; Cricca A; Pannuti F
    Eur J Cancer; 1995; 31A(1):127. PubMed ID: 7695965
    [No Abstract]   [Full Text] [Related]  

  • 19. Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.
    Cascinu S; Fedeli A; Catalano G
    Cancer Chemother Pharmacol; 1994; 34(1):72-4. PubMed ID: 8174205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer.
    Dreicer R; Forest PK; Williams RD
    Urology; 1994 Sep; 44(3):377-80. PubMed ID: 7521094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.